-
HEALTHCARE COSTS AND ECONOMIC BURDEN OF PATIENTS WITH SPINAL MUSCULAR ATROPHY (SMA) AND RELATED MOTOR NEURON DIAGNOSES IN TURKIYE: A REAL-WORLD DATA ANALYSIS
Aug 11, 2026, 17:16 PM -
HPV TESTING VERSUS VISUAL INSPECTION WITH ACETIC ACID FOR CERVICAL CANCER SCREENING IN MOROCCO . A COST-UTILITY ANALYSIS BASED ON A MARKOV MODEL
Aug 11, 2026, 17:16 PM -
TACKLING SOCIOECONOMIC INEQUALITIES ASSOCIATED WITH MENINGITIS AND ENCEPHALITIS AND THE ROLE OF RAPID MULTIPLEX TESTING
Aug 11, 2026, 17:16 PM -
ACCEPTANCE OF ARTIFICIAL INTELLIGENCE IN MEDICAL CONSULTATIONS: EVIDENCE FROM A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
ASSESSING THE INCREMENTAL VALUE OF PATIENT EXPERIENCE EVIDENCE IN HTA AND REIMBURSEMENT DECISION-MAKING
Aug 11, 2026, 17:16 PM -
GLOBAL BURDEN AND TEMPORAL TRENDS OF HIP OSTEOARTHRITIS: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND REAL-WORLD BURDEN OF ILLNESS IN PATIENTS WITH PD-L1-NEGATIVE METASTATIC TRIPLE-NEGATIVE BREAST CANCER IN THE FIRST-LINE SETTING
Aug 11, 2026, 17:16 PM -
COST-CONSEQUENCE ANALYSIS OF COVERED BALLOON-EXPANDABLE STENTS WITH PUBLISHED 3-YEAR OUTCOMES FOR AORTOILIAC OCCLUSIVE DISEASE IN THE UK
Aug 11, 2026, 17:16 PM -
GENESIS: AN OBSERVATIONAL DIGITAL STUDY REPORTING GENERAL POPULATION NORMS FOR THE I-RODS, MMN-RODS, CAP-PRI & GO-QOL IN 6 COUNTRIES
Aug 11, 2026, 17:16 PM -
ARE CURRENT EVIDENCE SYNTHESIS STANDARDS FIT FOR THE EU JOINT CLINICAL ASSESSMENT ERA? GAPS ACROSS PRISMA, COCHRANE, ISPOR, AND HTA GUIDANCE
Aug 11, 2026, 17:16 PM -
PORACTANT ALFA VERSUS CALFACTANT FOR NEONATAL RESPIRATORY DISTRESS SYNDROME: A MULTICENTER COST-EFFECTIVENESS STUDY
Aug 11, 2026, 17:16 PM -
HEALTH AND ECONOMIC IMPACT OF CATCH-UP RSV MAB IMMUNIZATION IN INFANTS IN GREECE
Aug 11, 2026, 17:16 PM -
SIMULATED COST IMPACT OF TRABECULAR MICRO-BYPASS IN A FIXED COHORT OF 55,000 PATIENTS UNDERGOING CATARACT SURGERY
Aug 11, 2026, 17:16 PM -
EVALUATING THE ECONOMIC IMPACT OF ADOPTING SELINEXOR-BASED THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN QATAR
Aug 11, 2026, 17:16 PM -
FREQUENCY AND ACCEPTABILITY OF SEVERITY MODIFIER IN NICE TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:16 PM -
DELPHI AND EXPERT CONSENSUS ACROSS THE PRODUCT LIFECYCLE: A FRAMEWORK TO ENHANCE REAL-WORLD EVIDENCE (RWE) PLANNING IN HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) AND HEALTH TECHNOLOGY ASSESSMENT (HTA)
Aug 11, 2026, 17:16 PM -
SELECTION OF BAYESIAN PRIOR DISTRIBUTIONS FOR BETWEEN-STUDY HETEROGENEITY IN RANDOM-EFFECTS NETWORK META-ANALYSIS MODELS VIA MARGINAL LIKELIHOODS
Aug 11, 2026, 17:16 PM -
WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN HUNTINGTON'S DISEASE: EVIDENCE FROM THE UK
Aug 11, 2026, 17:16 PM -
PARENT-CHILD AGREEMENT IN PEDIATRIC HRQOL MEASURED BY PEDSQL: DIFFERENCES BY DISEASE CHRONICITY AND CONTEXT
Aug 11, 2026, 17:16 PM -
CHARACTERIZING THE PRE-DIAGNOSTIC WORKUP GAP IN NEWLY DIAGNOSED TESTICULAR CANCER IN MALES AGED 15-45: ANALYSIS OF US REAL-WORLD DATA
Aug 11, 2026, 17:16 PM
